Nic Dakin – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Nic Dakin on 2016-09-06.

To ask the Secretary of State for Health, to what extent NICE has involved external stakeholders and charities in reviewing how well the incremental cost effectiveness ratio is working in making new cancer medicines available to patients on the NHS.

Nicola Blackwood

The National Institute for Health and Care Excellence (NICE) has advised that it has not been asked to review how well the application of the cost effectiveness methodology is working in making new cancer medicines available to patients on the National Health Service.

NICE periodically reviews its methods and processes for the development of guidance to ensure that they remain appropriate. NICE most recently consulted on changes to its methods for the appraisal of new cancer medicines in November 2015 as part of the consultation on the new operating model for the Cancer Drugs Fund.